1349 related articles for article (PubMed ID: 12730551)
21. Heterogeneity and immunochemical properties of anti-beta2-glycoprotein I autoantibodies.
Arvieux J; Regnault V; Hachulla E; Darnige L; Roussel B; Bensa JC
Thromb Haemost; 1998 Sep; 80(3):393-8. PubMed ID: 9759616
[TBL] [Abstract][Full Text] [Related]
22. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
23. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
[TBL] [Abstract][Full Text] [Related]
24. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
[TBL] [Abstract][Full Text] [Related]
25. Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation.
Arvieux J; Darnige L; Hachulla E; Roussel B; Bensa JC; Colomb MG
Thromb Haemost; 1996 May; 75(5):725-30. PubMed ID: 8725713
[TBL] [Abstract][Full Text] [Related]
26. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
28. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.
Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530
[TBL] [Abstract][Full Text] [Related]
30. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Satoh A; Suzuki K; Takayama E; Kojima K; Hidaka T; Kawakami M; Matsumoto I; Ohsuzu F
J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
[TBL] [Abstract][Full Text] [Related]
31. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
Dieudé M; Senécal JL; Raymond Y
Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
[TBL] [Abstract][Full Text] [Related]
32. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
[TBL] [Abstract][Full Text] [Related]
34. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
35. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies.
Zhu M; Olee T; Le DT; Roubey RA; Hahn BH; Woods VL; Chen PP
Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis.
Alessandri C; Sorice M; Bombardieri M; Conigliaro P; Longo A; Garofalo T; Manganelli V; Conti F; Esposti MD; Valesini G
Arthritis Res Ther; 2006; 8(6):R180. PubMed ID: 17150088
[TBL] [Abstract][Full Text] [Related]
38. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
39. High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome.
Ames PR; Matsuura E; Batuca JR; Ciampa A; Lopez LL; Ferrara F; Iannaccone L; Alves JD
Lupus; 2010 May; 19(6):711-6. PubMed ID: 20064910
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
